Cargando…
Putative biomarkers for predicting tumor sample purity based on gene expression data
BACKGROUND: Tumor purity is the percent of cancer cells present in a sample of tumor tissue. The non-cancerous cells (immune cells, fibroblasts, etc.) have an important role in tumor biology. The ability to determine tumor purity is important to understand the roles of cancerous and non-cancerous ce...
Autores principales: | Li, Yuanyuan, Umbach, David M., Bingham, Adrienna, Li, Qi-Jing, Zhuang, Yuan, Li, Leping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933652/ https://www.ncbi.nlm.nih.gov/pubmed/31881847 http://dx.doi.org/10.1186/s12864-019-6412-8 |
Ejemplares similares
-
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
por: Li, Yuanyuan, et al.
Publicado: (2019) -
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines
por: Li, Yuanyuan, et al.
Publicado: (2021) -
CDSeq: A novel complete deconvolution method for dissecting heterogeneous samples using gene expression data
por: Kang, Kai, et al.
Publicado: (2019) -
T-KDE: a method for genome-wide identification of constitutive protein binding sites from multiple ChIP-seq data sets
por: Li, Yuanyuan, et al.
Publicado: (2014) -
CDSeqR: fast complete deconvolution for gene expression data from bulk tissues
por: Kang, Kai, et al.
Publicado: (2021)